FDC vs TORNTPHARM: Stock Comparison

FDC Limited vs Torrent Pharmaceuticals Limited

Live data: 24 July 2026, 4:08 PM IST • Source: NSE and company filings

Torrent Pharmaceuticals Limited is the larger company by market capitalisation. FDC Limited shows a lower P/E, a higher dividend yield and lower leverage, while Torrent Pharmaceuticals Limited shows a higher ROE, faster revenue growth and a higher net margin. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of FDC Limited and Torrent Pharmaceuticals Limited on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, FDC is more favourable on 7 of 13 scored metrics and TORNTPHARM on 6These counts are context-free and are not an overall rating.

Key Differences

Market Cap
TORNTPHARM is the larger company
₹1.68 L Cr vs ₹6,606 Cr
P/E Ratio
FDC has a lower P/E
23.92x vs 77.69x
P/B Ratio
FDC has a lower P/B
2.71x vs 20.03x
EPS
TORNTPHARM has higher earnings per share
₹63.75 vs ₹17.27
Dividend Yield
FDC has a higher dividend yield
2.42% vs 0.9%
Revenue Growth (TTM YoY)
TORNTPHARM has faster revenue growth
41.8% vs 18.9%
EPS Growth (TTM YoY)
FDC has faster EPS growth
166.8% vs -21.7%
Qtr Sales Growth
TORNTPHARM has stronger quarterly sales growth
41.8% vs 18.9%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricFDCTORNTPHARM
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricFDCTORNTPHARM
Live Price₹412.95₹4,961.5
Day Change2.92%-2.05%
Volume96,7782.62 L
52-Week High₹527.8₹5,085.8
52-Week Low₹312.95₹3,480.6
Distance from 52W High-21.76%-2.44%

Valuation

MetricFDCTORNTPHARM
Market Cap₹6,606 Cr₹1.68 L Cr
P/E Ratio23.92x77.69x
P/B Ratio2.71x20.03x
EPS₹17.27₹63.75
Book Value₹152.62₹247.85
Dividend Yield2.42%0.9%

Growth

MetricFDCTORNTPHARM
Revenue Growth (TTM YoY)18.9%41.8%
EPS Growth (TTM YoY)166.8%-21.7%
Qtr Sales Growth18.9%41.8%
Qtr Profit Growth167%-20.6%

Profitability & Leverage

MetricFDCTORNTPHARM
ROE12.5%16.99%
ROCE16.7%15.2%
Net Margin12.96%15.73%
Operating Margin15.9%25.01%
Debt to Equity0.01x85.45x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricFDCTORNTPHARM
Promoter Holding69.66%68.31%
FII Holding1.4% 1 pp15.44% 0.74 pp
DII Holding6.31% 0.02 pp9.83% 0.77 pp
Public Holding22.63% 0.98 pp6.42% 0.03 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: FDC Limited and Torrent Pharmaceuticals Limited.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.